Please provide your feedback here
During the past two years, Stämm has designed a novel bioproduction system that leverages microfluidics, electroporation and robotics to solve the main constraint of the biotech industry: scaling up. Solving this problem could unlock a $700B market in the next 10 years.
Today, after integrating these state-of-the-art technologies, we are unveiling the future of biomanufacturing. We downsized a whole biotech plant into an all-in-one, plug-n-play desktop unit: the Bioprocessor.
Please login to explore more
Detailed profile data. Unlimited access for 1 year.
Top 5 Venture Capital funds in Argentina
Contxto – If Chile’s venture capital (VC) scene is crowded for such a small country, all while keeping swift and nimble—as we saw in last week’s VC ranking—, then this week’s featured country packs a punch with a just handful of players. Related articles: Top 7 Venture Capital funds in Chile The financial and economic […]
14 biotechs rewriting Argentina’s startup DNA
Contxto – Argentina’s startup ecosystem is already highly developed in various industries. There’s Mercado Libre in e-commerce and Ualá in fintech. But, the country is also becoming a major player in biotechnology. One well-established example of a success story is Rosario-based Bioceres which hit the New York Stock Exchange recently. And, in 2018, the government […]